Salutar Overview

  • Year Founded
  • 1983

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $55M

Salutar General Information

Description

Designer of biomimetic drug with focus to magnetic resonance imaging, radioisotopic agents for diagnosis and therapy. The company is involved in research and development of contrast agents for magnetic resonance imaging.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 428 Oakmead Pkwy
  • Sunnyvale, CA 94086
  • United States
Primary Industry
Drug Discovery
Acquirer
Hafslund
Corporate Office
  • 428 Oakmead Pkwy
  • Sunnyvale, CA 94086
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Salutar Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 28-Apr-1989 $55M 00.00 0000 Completed Generating Revenue
2. Early Stage VC 00.00 00.00 Completed Startup
1. Early Stage VC $600K $600K Completed Startup
To view Salutar’s complete valuation and funding history, request access »

Salutar Former Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Arthur Rock & Company PE/Buyout Minority 000 0000 000000 0
Hook Partners Venture Capital Minority 000 0000 000000 0
Mohr Davidow Ventures Venture Capital Minority 000 0000 000000 0
Sequoia Capital Venture Capital Minority 000 0000 000000 0
Venrock Venture Capital Minority 000 0000 000000 0
To view Salutar’s complete investors history, request access »

Ready to get started?

Request a free trial

Salutar FAQs

  • When was Salutar founded?

    Salutar was founded in 1983.

  • Who is the founder of Salutar?

    Steven Quay Ph.D is the founder of Salutar.

  • Where is Salutar headquartered?

    Salutar is headquartered in Sunnyvale, CA.

  • What industry is Salutar in?

    Salutar’s primary industry is Drug Discovery.

  • Is Salutar a private or public company?

    Salutar is a Private company.

  • What is the current valuation of Salutar?

    The current valuation of Salutar is 0000.

  • What is Salutar’s current revenue?

    The current revenue for Salutar is 00000.

  • How much funding has Salutar raised over time?

    Salutar has raised $7.7M.

  • Who are Salutar’s investors?

    Arthur Rock & Company, Hook Partners, Mohr Davidow Ventures, Sequoia Capital, and Venrock have invested in Salutar.

  • When was Salutar acquired?

    Salutar was acquired on 28-Apr-1989.

  • Who acquired Salutar?

    Salutar was acquired by Hafslund and Nycomed.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »